Hepatitis C Information Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatments here at Hepatitis-Central.com.

Hep C information
Free Newsletter
Hepatitis C Newsletter
We value your privacy. We will not rent your email to anyone.
HEPATITIS NEWS
The top stories compiled from over 5,500 sources, updated every 15 minutes

Hepatitis B, Chronic: Entecavir (NICE)
You must be a registered user to access the content and receive email bulletins from Healthcare Republic. If you have a paid subscription to MIMS or MIMS for Nurses, please activate your subscription. Otherwise, complete the free registration by choosing

Genelabs, NHRI collaborate on hepatitis C drug candidates
REDWOOD CITY, Calif.- has entered into a collaborative research agreement with the to discover and develop compounds that target the hepatitis C virus (HCV). HCV drug candidates will be developed using Genelabs' lead compounds on an existing target the

UPDATES AND COMMENTARY RSS Feed

Hep C Treatment: Comparing the Pegylated Interferons
Learn about the facts on pegylated interferon alfa-2a and pegylated interferon alfa-2b, the standard treatment for chronic Hepatitis C. Comparing and contrasting the pegylated interferons may help better explain a physician’s preference or indifference between the two when treating their...

Vertex's Advanced Trial Could Change HCV Treatment
Hundreds of non-responders to interferon-ribavirin combination therapy will be enrolled in a late stage clinical trial for Vertex's telaprevir....

Silymarin Improves Quality of Life During Hepatitis C Treatment
Although a large-scale study concluded long-term interferon therapy to be ineffectual for Hepatitis C management, it demonstrated improvements in quality of life for participants supplementing with silymarin....

10-Year Follow-up After Interferon-alpha Therapy for Chronic Hepatitis C

Fig. 4. Light microscopic findings on liver biopsies from a patient (number 9) who had a transient response to therapy with subsequent relapse. (A) Before therapy: HAI score = 17. (B) At the end of 12 months of therapy: HAI score = 10. (C) Eleven years after starting therapy: HAI score = 15. (Hematoxylin-eosin; original magnification ×20.)

Return to Article

table Of Contents

  Hep C information

Information at this website is for educational purposes only; statements about products and health conditions
have not been evaluated by the U.S. Food & Drug Administration.

©1994-2008 Hepatitis-Central.com
Updated 27 Aug 2008